Celldex Therapeutics reported $15K in Sales Revenues for its fiscal quarter ending in March of 2026.





Sales Change Date
AbbVie USD 15B 1.62B Mar/2026
Agenus USD 34.2M 3.97M Dec/2025
Amgen USD 8.62B 1.28B Mar/2026
Bristol-Myers Squibb USD 11.49B 1.01B Mar/2026
Celldex Therapeutics USD 15K 106K Mar/2026
Glaxosmithkline GBP 10.09B 1.37B Mar/2026
Nektar Therapeutics USD 21.81M 2.32M Dec/2025
Northwest Biotherapeutics USD 200K 245K Sep/2025
Pfizer USD 14.5B 3.08B Mar/2026
Rigel Pharmaceuticals USD 55.31M 18.47M Sep/2024
Roche Holding CHF 15.65B 274.5M Dec/2025